STOK logo

Stoke Therapeutics, Inc. (STOK) Free Cash Flow

Annual FCF:

-$87.05M-$4.37M(-5.29%)
December 31, 2024

Summary

  • As of today, STOK annual free cash flow is -$87.05 million, with the most recent change of -$4.37 million (-5.29%) on December 31, 2024.
  • During the last 3 years, STOK annual free cash flow has fallen by -$18.95 million (-27.82%).
  • STOK annual free cash flow is now -1483.66% below its all-time high of -$5.50 million, reached on December 31, 2017.

Performance

STOK Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

Quarterly FCF:

-$30.50M-$4.92M(-19.24%)
September 30, 2025

Summary

  • As of today, STOK quarterly free cash flow is -$30.50 million, with the most recent change of -$4.92 million (-19.24%) on September 30, 2025.
  • Over the past year, STOK quarterly free cash flow has dropped by -$8.78 million (-40.43%).
  • STOK quarterly free cash flow is now -123.16% below its all-time high of $131.68 million, reached on March 31, 2025.

Performance

STOK Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

TTM FCF:

$52.37M-$8.78M(-14.36%)
September 30, 2025

Summary

  • As of today, STOK TTM free cash flow is $52.37 million, with the most recent change of -$8.78 million (-14.36%) on September 30, 2025.
  • Over the past year, STOK TTM free cash flow has increased by +$137.06 million (+161.83%).
  • STOK TTM free cash flow is now -24.33% below its all-time high of $69.20 million, reached on March 31, 2025.

Performance

STOK TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

STOK Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-5.3%-40.4%+161.8%
3Y3 Years-27.8%-26.6%+277.5%
5Y5 Years-166.3%-165.2%+220.7%

STOK Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-143.0%at low-123.2%at low-24.3%+157.5%
5Y5-Year-166.3%at low-123.2%at low-24.3%+157.5%
All-TimeAll-Time-1483.7%at low-123.2%at low-24.3%+157.5%

STOK Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$30.50M(-19.2%)
$52.37M(-14.4%)
Jun 2025
-
-$25.58M(-119.4%)
$61.15M(-11.6%)
Mar 2025
-
$131.68M(+666.7%)
$69.20M(+179.5%)
Dec 2024
-$87.05M(-5.3%)
-$23.23M(-7.0%)
-$87.05M(-2.8%)
Sep 2024
-
-$21.72M(-23.9%)
-$84.70M(-5.1%)
Jun 2024
-
-$17.52M(+28.7%)
-$80.62M(+6.0%)
Mar 2024
-
-$24.58M(-17.7%)
-$85.74M(-3.7%)
Dec 2023
-$82.68M(-130.8%)
-$20.88M(-18.3%)
-$82.68M(+2.3%)
Sep 2023
-
-$17.64M(+22.1%)
-$84.59M(+7.1%)
Jun 2023
-
-$22.64M(-5.2%)
-$91.03M(-2.3%)
Mar 2023
-
-$21.52M(+5.5%)
-$89.00M(-148.4%)
Dec 2022
-$35.83M(+47.4%)
-$22.78M(+5.4%)
-$35.83M(-21.4%)
Sep 2022
-
-$24.09M(-16.9%)
-$29.51M(-44.8%)
Jun 2022
-
-$20.61M(-165.1%)
-$20.38M(-26.4%)
Mar 2022
-
$31.65M(+292.3%)
-$16.12M(+76.3%)
DateAnnualQuarterlyTTM
Dec 2021
-$68.11M(-57.4%)
-$16.46M(-10.1%)
-$68.11M(-9.0%)
Sep 2021
-
-$14.96M(+8.5%)
-$62.49M(-5.8%)
Jun 2021
-
-$16.35M(+19.6%)
-$59.03M(-12.6%)
Mar 2021
-
-$20.34M(-87.6%)
-$52.41M(-20.6%)
Dec 2020
-$43.27M(-32.4%)
-$10.84M(+5.8%)
-$43.45M(-0.2%)
Sep 2020
-
-$11.50M(-18.2%)
-$43.38M(-7.1%)
Jun 2020
-
-$9.73M(+14.5%)
-$40.51M(-8.2%)
Mar 2020
-
-$11.38M(-5.7%)
-$37.45M(-14.6%)
Dec 2019
-$32.69M(-174.7%)
-$10.77M(-24.8%)
-$32.69M(-49.1%)
Sep 2019
-
-$8.63M(-29.5%)
-$21.92M(-64.9%)
Jun 2019
-
-$6.67M(-0.6%)
-$13.29M(-100.6%)
Mar 2019
-
-$6.62M(-228.7%)
-$6.62M(-228.7%)
Dec 2018
-$11.90M(-116.5%)
-
-
Mar 2018
-
-$2.02M
-$2.02M
Dec 2017
-$5.50M
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Stoke Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of STOK is -$87.05M

What is the all-time high annual free cash flow for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual free cash flow is -$5.50M

What is Stoke Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, STOK annual free cash flow has changed by -$4.37M (-5.29%)

What is Stoke Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of STOK is -$30.50M

What is the all-time high quarterly free cash flow for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly free cash flow is $131.68M

What is Stoke Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, STOK quarterly free cash flow has changed by -$8.78M (-40.43%)

What is Stoke Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of STOK is $52.37M

What is the all-time high TTM free cash flow for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM free cash flow is $69.20M

What is Stoke Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, STOK TTM free cash flow has changed by +$137.06M (+161.83%)
On this page